| Ms Ashley Liana Screws, MD | |
|
200 Jefferson Ave Se, Grand Rapids, MI 49503-4502 | |
| (616) 685-5000 | |
| Not Available |
| Full Name | Ms Ashley Liana Screws |
|---|---|
| Gender | Female |
| Speciality | Anesthesiology |
| Experience | 12 Years |
| Location | 200 Jefferson Ave Se, Grand Rapids, Michigan |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1073878500 | NPI | - | NPPES |
| 017620800 | Medicaid | FL |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | ME127693 (Florida) | Secondary |
| 207L00000X | Anesthesiology | 4301113178 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mercy Health Saint Mary's | Grand rapids, MI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Saint Marys Health Services | 4981500436 | 163 |
News Archive
Having recently discovered a set of powerful gene regulators that control cell identity in a few mouse and human cell types, Whitehead Institute scientists are now showing that these regulators-which they named "super-enhancers"-act across a vast array of human cell types and are enriched in mutated regions of the genome that are closely associated with a broad spectrum of diseases.
IOS Press is pleased to announce the 20th anniversary of the peer-reviewed journal Restorative Neurology and Neuroscience. Since founded in 1989 by pioneering neuroscientist Donald G. Stein, RNN has focused on the emerging field of brain plasticity, repair and rehabilitation and has published not only numerous original scientific publications, but also review papers in basic research (animal experiments, in vitro studies) and in the clinical sciences.
Catalyst Health Solutions, Inc. today announced it has completed its acquisition of Walgreens' pharmacy benefit management (PBM) subsidiary, Walgreens Health Initiatives, Inc. (WHI). Catalyst funded the transaction with a combination of cash on hand and amounts available under its credit facility.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
› Verified 1 days ago
| Entity Name | Saint Marys Health Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1124063078 PECOS PAC ID: 4981500436 Enrollment ID: O20040329001233 |
News Archive
Having recently discovered a set of powerful gene regulators that control cell identity in a few mouse and human cell types, Whitehead Institute scientists are now showing that these regulators-which they named "super-enhancers"-act across a vast array of human cell types and are enriched in mutated regions of the genome that are closely associated with a broad spectrum of diseases.
IOS Press is pleased to announce the 20th anniversary of the peer-reviewed journal Restorative Neurology and Neuroscience. Since founded in 1989 by pioneering neuroscientist Donald G. Stein, RNN has focused on the emerging field of brain plasticity, repair and rehabilitation and has published not only numerous original scientific publications, but also review papers in basic research (animal experiments, in vitro studies) and in the clinical sciences.
Catalyst Health Solutions, Inc. today announced it has completed its acquisition of Walgreens' pharmacy benefit management (PBM) subsidiary, Walgreens Health Initiatives, Inc. (WHI). Catalyst funded the transaction with a combination of cash on hand and amounts available under its credit facility.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Ashley Liana Screws, MD 1600 Sw Archer Rd, Gainesville, FL 32610-3003 Ph: (325) 265-0301 | Ms Ashley Liana Screws, MD 200 Jefferson Ave Se, Grand Rapids, MI 49503-4502 Ph: (616) 685-5000 |
News Archive
Having recently discovered a set of powerful gene regulators that control cell identity in a few mouse and human cell types, Whitehead Institute scientists are now showing that these regulators-which they named "super-enhancers"-act across a vast array of human cell types and are enriched in mutated regions of the genome that are closely associated with a broad spectrum of diseases.
IOS Press is pleased to announce the 20th anniversary of the peer-reviewed journal Restorative Neurology and Neuroscience. Since founded in 1989 by pioneering neuroscientist Donald G. Stein, RNN has focused on the emerging field of brain plasticity, repair and rehabilitation and has published not only numerous original scientific publications, but also review papers in basic research (animal experiments, in vitro studies) and in the clinical sciences.
Catalyst Health Solutions, Inc. today announced it has completed its acquisition of Walgreens' pharmacy benefit management (PBM) subsidiary, Walgreens Health Initiatives, Inc. (WHI). Catalyst funded the transaction with a combination of cash on hand and amounts available under its credit facility.
Abbott today announced positive six-month results from the first 45 patients enrolled in the second stage of the ABSORB trial, which was presented during the Late-Breaking Clinical Trials session at the EuroPCR 2010 conference. At six months, Abbott's bioresorbable vascular scaffold (BVS) demonstrated strong results, with a low (4.4 percent) rate of major adverse cardiac events (MACE) and no blood clots (thromboses).
› Verified 1 days ago
Matthew H Armstrong, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Michigan St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 | |
Daniel H. Robinson, D.O. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-5000 | |
Cheryl Lukins, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 25 Michigan St Ne Ste 2200, Grand Rapids, MI 49503 Phone: 616-391-3245 | |
Dr. Jeffrey M Ricketts, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 3333 Evergreen Dr Ne, Grand Rapids, MI 49525 Phone: 616-364-4200 Fax: 616-364-7347 | |
Christopher Ross Russo, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 710 Kenmoor Ave Se, Suite 200, Grand Rapids, MI 49546 Phone: 616-588-7246 Fax: 616-588-7086 | |
Samuel Lee, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Michign St Ne, Grand Rapids, MI 49503 Phone: 616-364-4200 | |
Dr. Cindy Chu, DO Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 200 Jefferson Ave Se, Grand Rapids, MI 49503 Phone: 616-685-5000 |